Cargando…
Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID‐19 infection: A case report with detailed laboratory data
The administration of glucocorticoid and hydroxychloroquine (HCQ) may be able to control systemic lupus erythematosus (SLE) activities under COVID‐19 infection by suppress the cytokine storm.
Autores principales: | Kondo, Makoto, Matsushima, Yoshiaki, Iida, Shohei, Umaoka, Ai, Nakanishi, Takehisa, Habe, Koji, Yamanaka, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385256/ https://www.ncbi.nlm.nih.gov/pubmed/34466256 http://dx.doi.org/10.1002/ccr3.4700 |
Ejemplares similares
-
Lymphocyte transformation test: The multiple positive results turned to all negative after influenza infection
por: Kondo, Makoto, et al.
Publicado: (2021) -
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
por: Kondo, Makoto, et al.
Publicado: (2021) -
Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model
por: Nakanishi, Takehisa, et al.
Publicado: (2021) -
Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks
por: Kondo, Makoto, et al.
Publicado: (2023) -
Seborrheic Keratosis Caused by Human Papillomavirus Type 20 Ameliorated by Zinc Oxide Ointment
por: Kondo, Makoto, et al.
Publicado: (2023)